Is there still a need for albumin infusions to treat patients with liver disease?
Ginès
P
P
Liver Unit Institut de Malalties Digestives Hospital Clínic Barcelona, Spain. gines@medicina.ub.es
Arroyo
V
V
D000418:Albumins / Q000627:therapeutic use*; D001201:Ascites / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D001810:Blood Volume / Q000187:drug effects; D004359:Drug Therapy, Combination; D006530:Hepatorenal Syndrome / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D009951:Ornipressin / Q000627:therapeutic use; D010952:Plasma Substitutes / Q000627:therapeutic use*; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D000418:Albumins; D010952:Plasma Substitutes; D014662:Vasoconstrictor Agents; D009951:Ornipressin